Mathilde Richard (1985) is a molecular virologist. She completed her PhD in 2010 in France under the supervision of Prof. Bruno Lina with a dissertation on resistance of influenza A viruses to neuraminidase inhibitors. She then integrated the department of Viroscience for her post-doctoral studies, which have focused on the pathogenesis, virulence and transmissibility of influenza A viruses, with special emphasis on genetic and phenotypic viral factors involved in the emergence of new pandemics. On this thematic, she was involved in European projects (Antigone, Aditec, Emperie and Compare)
The research of her team focusses on the antigenic evolution of H5 highly pathogenic avian influenza viruses and the development of new vaccination strategies to cope with antigenic diversity in the context of pandemic preparedness.
Field(s) of expertise
What research group(s) or lab(s) do you participate in?
Scholarships, grants, and awards
• Dr. Kirsty Short (University of Queensland, Australia)
• Prof. Nynke Dekker (Delft University of Technology, the Netherlands)
• Dr. Aartjan te Velthuis (University of Cambridge, UK)
• Dr. Anice Lowen (Emory University of School of Medicine, USA)